Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
about
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremiaHigh-efficiency dialysis for carbamazepine overdose.Practical vancomycin dosing in hemodialysis patients in the era of emerging vancomycin resistance: a single-center experience.Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of AmericaVancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysisStaphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Central venous dialysis catheters: catheter-associated infection.Understanding drug ototoxicity: molecular insights for prevention and clinical management.Factors influencing vancomycin loading dose for hospitalized hemodialysis patients: prospective observational cohort studyTreatment of dialysis catheter-related Enterococcus bacteremia with an antibiotic lock: a quality improvement report.Vancomycin dosing in patients on intermittent hemodialysis.Antibiotic Dosing in Patients With Acute Kidney Injury: "Enough But Not Too Much".Vancomycin: the tale of the vanquisher and the pyrrhic victory.Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile.The Nephrotoxicity of VancomycinPredicting Maintenance Doses of Vancomycin for Hospitalized Patients Undergoing HemodialysisEvaluation of weight-based vancomycin dosing for hospitalized hemodialysis patients.Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen.Application of Intrawound Vancomycin Powder during Spine Surgery in a Patient with Dialysis-Dependent Renal Failure.Treatment guidelines for dialysis catheter-related bacteremia: an update.Prevention and Therapy of Acute Kidney Injury in the Developing World.The ratio of pre-dialysis vancomycin trough serum concentration to minimum inhibitory concentration is associated with treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia.
P2860
Q21261829-667FE726-B290-4A02-8264-98BF7D8DB866Q33332901-169706A5-A8DE-4A6F-992D-236321D8E9D7Q33602468-A2D5335C-146D-4374-A39F-682C3E333B33Q33688646-B747FC73-C7BC-46FA-9195-BDDB8C333311Q34405301-19A61F69-D16E-41A3-8363-CCCC5FCBEFE1Q34478074-C0D37D00-C849-4AEE-9D6F-F89066CC5EEAQ34536206-A066A02B-4573-406A-9C90-B2ADA1F25539Q36446895-A5EEBFFD-539A-4F6F-B949-11D2E3308FA3Q36454724-8F70BEF6-97D6-4460-A28F-D485F1F42C0BQ37037640-EABCF481-7C31-4876-BB02-E7A57295400EQ37845424-500B5A34-AEB2-48A8-9227-23EC1FBEDF0DQ38261172-0D012C2D-0CDB-42D2-88ED-5F1F258EE750Q38542797-E0A68680-46E7-49AC-B18B-594246C1057DQ38545589-F6FE7AD7-CEFC-45E1-9DE1-546C4DD0213EQ38687487-719EB677-E41D-475E-9ED0-F14FB6C02155Q39203427-37623910-004C-4B5B-8EAB-D8F16B6060B2Q40499611-11AE0F21-ADE1-4964-91A1-7C09655782E1Q40539300-7D3F537E-710A-41A6-B6CC-1F620B2C3533Q41103109-C077F416-C1EF-447E-9CED-C64C263A6A89Q42720835-F47E24F9-05B7-49E8-BCDE-EBA8043CA818Q47361874-45AF069A-44BC-4AA5-9F76-2BE7EEE921E8Q53704626-5D6E96A5-863B-4AF1-BA71-9A413CDE4FC9
P2860
Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
@en
Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
@nl
type
label
Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
@en
Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
@nl
prefLabel
Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
@en
Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
@nl
P356
P1433
P1476
Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
@en
P2093
DeVincenzo N
P2888
P304
P356
10.1038/KI.1996.393
P407
P577
1996-09-01T00:00:00Z
P6179
1025728216